CLSI M24A

Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24-A

Clinical and Laboratory Standards Institute, 04/01/2003

Publisher: CLSI

File Format: PDF

$135.00$271.99

Description

Published:01/04/2003

Pages:71

CLSI M24A provides protocols and related quality control parameters and interpretive criteria for the susceptibility testing of mycobacteria, Nocardiae spp. and other aerobic actinomycetes.

More CLSI standard pdf

CLSI M44A

Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline, M44-A

$135.00 $270.18

CLSI GP17A2

Clinical Laboratory Safety; Approved Guideline, GP17-A2

$118.00 $236.69

CLSI M22-A3 (R2018)

Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard, M22A3E

$90.00 $180.00

CLSI M31S1

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Informational Supplement, M31-S1

$90.00 $180.00